Fatty acids, rape-oil, hydrogenated, reaction products with diethylenetriamine, di-Me sulfate-quaternized

Acute Toxicity: dermal

Administrative data

Endpoint:

acute toxicity: dermal

Type of information:

experimental study

Adequacy of study:

key study

Study period:

From May 11, 2010 to May 25, 2010

Reliability:

1 (reliable without restriction)

Rationale for reliability incl. deficiencies:

guideline study

Data source

Reference

Reference Type:

study report

Title:

Unnamed

Year:

2010

Report date:

2010

Materials and methods

Test guideline

Qualifier:

according to guideline

Guideline:

OECD Guideline 402 (Acute Dermal Toxicity)

Deviations:

no

GLP compliance:

yes

Test type:

standard acute method

Limit test:

yes

Test material

Test material information

Constituent 1

Reference substance name:

Fatty acids, rape-oil, hydrogenated, reaction products with diethylenetriamine, di-Me sulfate-quaternized

EC Number:

306-529-6

EC Name:

Fatty acids, rape-oil, hydrogenated, reaction products with diethylenetriamine, di-Me sulfate-quaternized

Cas Number:

97281-29-3

Molecular formula:

Molecular formula of major constituents: C42H85N3O5S1 (C18 carbon chain) C46H93N3O5S1 (C20 carbon chain) C50H101N3O5S1 (C22 carbon chain)

IUPAC Name:

Fatty acids, C18-22 (even numbered), reaction products with diethylenetriamine, di-Me sulfate-quaternized

Test material form:

solid

Test animals

Species:

rabbit

Strain:

New Zealand White

Sex:

male/female

Details on test animals or test system and environmental conditions:

Source: Covance Research Products, Inc., Denver
Acclimation: 7 days
Body weights: 2.6 - 3.0 kg for males and 2.9 - 3.3 kg for females
Diet: Fresh PMI Rabbit Chow
Water: ad libitum
Light changes: 12h / 12h

Administration / exposure

Type of coverage:

semiocclusive

Vehicle:

water

Remarks:

To obtain a paste

Details on dermal exposure:

10% of the total body surface (clipped free of hair)
Amount: 3.5 mL

Duration of exposure:

24 h

Doses:

2000 mg/kg bw

No. of animals per sex per dose:

5

Control animals:

no

Details on study design:

The test substance was kept in contact with the skin for 24 h. Dermal responses at test sites were recorded at 24 h postdose and on days 7 and 14 using the numerical Draize scoring. The skin was also evaluated for ulceration and necrosis or any evidence of tissue destruction. Animals were observed for toxicity and pharmacological effects at 1, 2 and 4 h after application and once daily for 14 days. All animals were observed twice daily for mortality. Body weight were recorded pretest, weekly and at termination. Finally, rabbits were examined for gross pathology.

Results and discussion

Effect levels

Key result

Sex:

male/female

Dose descriptor:

LD50

Effect level:

> 2 000 mg/kg bw

Based on:

test mat.

Mortality:

All animals survived the dermal application

Clinical signs:

other: Instances of few feces were observed in one animal. There were no other abnormal signs noted during the observation period. Neither erythema nor oedema was detected.

Gross pathology:

Necropsy results were normal.

Applicant's summary and conclusion

Interpretation of results:

other: CLP criteria not met

Conclusions:

Under the study conditions, the rabbit dermal LD50 was determined to > 2000 mg/kg bw.

Executive summary:

A study was conducted to determine the acute dermal toxicity of the test substance, 'di-C18-22 AAEMIM-MS' (active: 100%), according to OECD Guideline 402, in compliance with GLP. Five male and five female New Zealand White rabbits were exposed to 2000 mg/kg bw test substance (3.5 mL in water) under a semi-occlusive type of coverage on a clipped skin free of hair. The test substance was kept in contact with the skin for 24 hours. Dermal responses at test sites were recorded at 24 h postdose and on days 7 and 14 using the numerical Draize scoring. The skin was also evaluated for ulceration and necrosis or any evidence of tissue destruction. Animals were observed for toxicity and pharmacological effects at 1, 2 and 4 hours after application and once daily for 14 days. Mortality was checked twice daily. Body weight was recorded pre-test, weekly and at termination. Finally, rabbits were examined for gross pathology. All animals survived the dermal application. Instances of few faeces were observed in one animal. There were no other abnormal signs noted during the observation period. Neither erythema nor oedema was detected. Body weight changes and gross examination were normal. Under the study conditions, the rabbit dermal LD50 was determined to > 2000 mg/kg bw (MBRL, 2010).